Of these, 359 million have been administered. Another 2.1 million doses are expected to land in the country this weekend, the Health Ministry reported.
Approval was announced today (16), after a technical evaluation by the agency, on the request presented in November, indicating the use of the vaccine for children aged 5 to 11 years.
The information is contained in the first edition of the bulletin on the effectiveness of vaccines against covid-19 in the Brazilian population, from the Vigivac project by Fiocruz, published on the 9th.
Pharmacists say they continue to make progress in developing a vaccine that is specific for Ômicron.